Chandra Bhagat Pharma Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Chandra Bhagat Pharma Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $1.8M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Chandra Bhagat Pharma Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $1.8M Trade | TransData Nexus

Who is Chandra Bhagat Pharma Private Limited? — Company Overview & Market Position

Chandra Bhagat Pharma Private Limited, established on March 10, 2003, is a Mumbai-based pharmaceutical company specializing in the marketing and export of critical care and healthcare products. The company was founded by Mr. Hemant Chandravadan Bhagat and his father, the late Mr. Chandravadan Bhagat, who had a longstanding presence in the pharmaceutical industry. Initially incorporated as a private limited entity, it transitioned to a public limited company on March 20, 2019.

The company's registered office is located at 323-F Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East), Mumbai, Maharashtra, India, 400019. As of the latest available data, Chandra Bhagat Pharma has an authorized capital of ₹8.5 crore and a paid-up capital of ₹7.55 crore. The company is listed on the Bombay Stock Exchange under the ticker symbol 542934.

What Does Chandra Bhagat Pharma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Salbutamol$1.4M 2Cyclosporine$256.4K 3Amikacin$200.0K

Chandra Bhagat Pharma Private Limited Therapeutic Categories — 3 Specializations

Chandra Bhagat Pharma Private Limited operates across 3 therapeutic categories, with Respiratory (74.8%), Immunosuppressants (14.1%), Advanced Antibiotics (11.0%) representing the largest segments by export value. The portfolio is concentrated — the top 5 products account for 100% of total exports.

Respiratory

1 products · 74.8% · $1.4M

Immunosuppressants

1 products · 14.1% · $256.4K

Advanced Antibiotics

1 products · 11.0% · $200.0K

Product Portfolio — Top 3 by Export Value

Chandra Bhagat Pharma Private Limited exports 3 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Salbutamol	Respiratory	$1.4M	40	0.9%	9
2	Cyclosporine

Key Metrics

Total Trade$1.8M

Products3

Shipments54

Categories3

#1 Rankings0

Top 5 Concentration100.0%

Top Categories

Respiratory74.8%

Immunosuppressants14.1%

Advanced Antibiotics11.0%

Last updated: March 28, 2026

Chandra Bhagat Pharma Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Chandra Bhagat Pharma Private Limited operates manufacturing facilities in Mumbai, Maharashtra, India. The company specializes in the production of finished pharmaceutical formulations, including intravenous (IV) and intramuscular (IM) injections, tablets, and capsules. These products cater to various therapeutic categories such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology.

Chandra Bhagat Pharma Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Chandra Bhagat Pharma Private Limited operates in a competitive pharmaceutical market, with numerous companies offering similar therapeutic products. While specific competitors are not identified in the available sources, the company's focus on critical care and healthcare products positions it within a niche segment. The company's diversified product portfolio across various therapeutic categories, including anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology, allows it to cater to a broad patient base, potentially enhancing its competitive edge.

2Key Differentiators

Chandra Bhagat Pharma Private Limited's key differentiators include its extensive experience in the pharmaceutical industry, a diversified product portfolio covering a wide range of therapeutic categories, and a commitment to quality manufacturing practices. The company's focus on critical care and healthcare products, along with its established distribution network, enables it to effectively serve both domestic and international markets.

3Strategic Position

Chandra Bhagat Pharma Private Limited's current strategic direction emphasizes the marketing and export of pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules, across various therapeutic categories. The company's diversified product portfolio and international market presence suggest a focus on both generics and branded products. While specific plans regarding specialty drugs, biosimilars, or Contract Development and Manufacturing Organization (CDMO) services are not detailed in the available sources, the company's established infrastructure and market reach position it well for future growth and expansion in these areas.

TransData Nexus Research · DGFT export records, industry analysisMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Supplier Matching: Chandra Bhagat Pharma Private Limited identified across shipments using name normalization, aggregating 2 name variants.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
3.Market Share: Calculated per product as Chandra Bhagat Pharma Private Limited's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 54 individual customs records matching Chandra Bhagat Pharma Private Limited.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3 Products Tracked

3 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Chandra Bhagat Pharma Private Limited

Chandra Bhagat Pharma Private Limited — Export Portfolio & Destination Treemap

Who is Chandra Bhagat Pharma Private Limited? — Company Overview & Market Position

What Does Chandra Bhagat Pharma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

Chandra Bhagat Pharma Private Limited Therapeutic Categories — 3 Specializations

Product Portfolio — Top 3 by Export Value

Key Metrics

Top Categories

Chandra Bhagat Pharma Private Limited — Corporate Profile & Information

1Corporate Overview

2Manufacturing Facilities

Top Export Routes

Related Analysis

Need Detailed Data?

3Key Leadership

Where Does Chandra Bhagat Pharma Private Limited Export? — Destination Intelligence

1Regulated Markets

2Emerging Markets

3Geographic Strategy

Chandra Bhagat Pharma Private Limited — Manufacturing & Regulatory Profile

1FDA Status

2WHO & EU GMP

3CDSCO & Indian Regulatory

4Recent Regulatory Actions

Chandra Bhagat Pharma Private Limited — Competitive Positioning Among Indian Pharma Exporters

1Competitive Landscape

2Key Differentiators

3Strategic Position

Buyer Due Diligence Brief — Evaluating Chandra Bhagat Pharma Private Limited as a Supplier

1Supplier Assessment

2Certifications to Verify

Frequently Asked Questions — Chandra Bhagat Pharma Private Limited

How many pharmaceutical products does Chandra Bhagat Pharma Private Limited export from India?

What is Chandra Bhagat Pharma Private Limited's total pharmaceutical export value?

What therapeutic categories does Chandra Bhagat Pharma Private Limited cover?

Get Full Chandra Bhagat Pharma Private Limited Export Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology